Skip to main content

Xenetic Biosciences, Inc.

XBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534525

No open-market purchases or sales by Xenetic Biosciences, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $442.8K in total; no superinvestor holds it.

Superinvestors holding XBIO, Q2 2026

See all superinvestors

No superinvestor reported holding XBIO in Q2 2026.